13F-HR filed by ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-11-14, with 130 holding rows worth $9,573,927,000.
- Accession
- 0001172661-14-001849
- Filer
- CIK 1055951
- Filed
- 2014-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2014
A holdings report, 130 entries on the cover page, a total value of $9,573,927,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $9,573,927,000 with VALUE read as thousands by filing date, 13F file number 028-06774. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerORBIMED CAPITAL LLC028-10410
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 3,762,200 | $400,486,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 1,190,100 | $393,697,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 7,292,000 | $373,205,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 2,603,000 | $365,617,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 1,485,000 | $351,485,000 | thousands by filing date | |
| ACTAVIS PLC | G0083B108 | SHS | 1,436,200 | $346,526,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 5,478,000 | $316,409,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 1,219,000 | $315,782,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 3,328,000 | $315,428,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 4,213,000 | $297,101,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 950,000 | $246,098,000 | thousands by filing date | call |
| MEDIVATION INC | 58501N101 | COM | 2,273,000 | $224,732,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 1,343,000 | $220,145,000 | thousands by filing date | |
| CAREFUSION CORP | 14170T101 | COM | 4,756,000 | $215,209,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 1,691,400 | $205,843,000 | thousands by filing date | |
| RELYPSA INC | 759531106 | Common Stock | 8,857,551 | $186,806,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 386,400 | $178,447,000 | thousands by filing date | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 1,142,700 | $177,976,000 | thousands by filing date | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 4,299,000 | $175,165,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 1,144,700 | $171,922,000 | thousands by filing date | |
| ALLERGAN INC | 018490102 | COM | 897,700 | $159,961,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 3,254,900 | $159,653,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 2,662,000 | $157,803,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 12,012,100 | $155,617,000 | thousands by filing date | |
| IMPAX LABORATORIES INC | 45256B101 | COM | 6,405,200 | $151,867,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 1,350,000 | $151,619,000 | thousands by filing date | |
| EXPRESS SCRIPTS HLDG CO | 30219G108 | COM | 2,098,000 | $148,182,000 | thousands by filing date | |
| Lowes Companies Inc | 42222G108 | LOW | 3,070,400 | $141,576,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 708,000 | $137,826,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 369,600 | $133,248,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 1,259,700 | $126,663,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 2,737,900 | $115,813,000 | thousands by filing date | |
| TORNIER NV | N87237108 | COMMON STOCK-FO | 4,805,000 | $114,840,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 5,793,600 | $90,786,000 | thousands by filing date | |
| Stryker Corporation | 863667101 | COM | 1,002,600 | $80,960,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 2,670,000 | $78,952,000 | thousands by filing date | |
| ARROWHEAD RESEARCH CORP | 042797209 | COM | 5,178,200 | $76,482,000 | thousands by filing date | |
| WRIGHT MED GROUP INC | 98235T107 | COM | 2,444,000 | $74,053,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 1,953,000 | $71,968,000 | thousands by filing date | |
| SPY | 78462F103 | SHS | 350,000 | $68,957,000 | thousands by filing date | put |
| NPS PHARMACEUTICALS INC | 62936P103 | COM | 2,616,000 | $68,016,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 4,736,900 | $63,569,000 | thousands by filing date | |
| ST JUDE MED INC | 790849103 | COM | 1,023,600 | $61,549,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 2,256,398 | $54,154,000 | thousands by filing date | |
| AFFYMETRIX INC | 00826T108 | COM | 6,568,000 | $52,413,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 312,000 | $51,736,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 2,100,200 | $51,455,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 212,900 | $50,792,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 423,000 | $45,088,000 | thousands by filing date | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 5,372,000 | $38,786,000 | thousands by filing date | |
| QIAGEN NV | N72482107 | COMMON STOCK-FO | 1,700,000 | $38,709,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 5,814,630 | $36,632,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 662,000 | $35,583,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 1,723,000 | $33,392,000 | thousands by filing date | |
| ROKA BIOSCIENCE INC | 775431109 | COM | 3,220,429 | $32,365,000 | thousands by filing date | |
| SALIX PHARMACEUTICALS INC | 795435106 | COM | 200,000 | $31,248,000 | thousands by filing date | call |
| THE COOPER COMPANIES | 216648402 | COM NEW | 200,000 | $31,150,000 | thousands by filing date | call |
| XENOPORT INC | 98411C100 | COM | 5,546,100 | $29,838,000 | thousands by filing date | |
| CERUS CORP | 157085101 | COM | 7,185,000 | $28,812,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 2,175,857 | $28,569,000 | thousands by filing date | |
| INSYS THERAPEUTICS INC | 45824V209 | COMMON STOCK | 735,600 | $28,527,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 2,181,600 | $28,274,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 200,000 | $28,092,000 | thousands by filing date | call |
| Mallinckrodt Plc | G5785G107 | SHS | 294,001 | $26,504,000 | thousands by filing date | |
| MEDTRONIC INC | 585055106 | COM | 423,300 | $26,223,000 | thousands by filing date | |
| INCYTE CORP | 45337CAJ1 | NOTE 4.750%10/0 | 4,242,000 | $23,161,000 | thousands by filing date | principal |
| NUVASIVE INC | 670704105 | COM | 662,000 | $23,084,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 237,900 | $23,057,000 | thousands by filing date | |
| AMBIT BIOSCIENCES CORP | 02318X100 | COM | 1,490,769 | $22,958,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 6,402,800 | $22,858,000 | thousands by filing date | |
| DURATA THERAPEUTICS INC | 26658A107 | COM | 1,785,714 | $22,643,000 | thousands by filing date | |
| MAGELLAN HEALTH SERVICES INC | 559079207 | COM NEW | 402,600 | $22,034,000 | thousands by filing date | |
| COVIDIEN PLC | G2554F113 | SHS | 250,000 | $21,628,000 | thousands by filing date | call |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 850,700 | $21,506,000 | thousands by filing date | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 277,000 | $20,753,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,167,000 | $20,434,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385PAA6 | NOTE 2.750% 2/0 | 21,935,000 | $18,645,000 | thousands by filing date | principal |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 115,000 | $18,464,000 | thousands by filing date | |
| VALEANT PHARMACEUTICALS INTL | 91911K102 | COM | 138,000 | $18,106,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 221,000 | $17,868,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 200,000 | $17,250,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 537,335 | $16,926,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 950,000 | $16,331,000 | thousands by filing date | |
| COVIDIEN PLC | G2554F113 | SHS | 180,600 | $15,624,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 300,000 | $15,354,000 | thousands by filing date | call |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 60,000 | $14,314,000 | thousands by filing date | call |
| WELLPOINT INC | 94973V107 | COM | 118,500 | $14,175,000 | thousands by filing date | |
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 2,821,500 | $13,571,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 1,924,500 | $13,279,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 338,800 | $13,189,000 | thousands by filing date | |
| VOLCANO CORP | 928645AB6 | CORPORATE OBLIG | 15,000,000 | $12,994,000 | thousands by filing date | principal |
| SALIX PHARMACEUTICALS INC | 795435106 | COM | 82,000 | $12,812,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 1,075,400 | $12,614,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 3,586,100 | $11,153,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 896,000 | $11,003,000 | thousands by filing date | |
| XOMA CORP DEL | 98419J107 | COM | 2,437,000 | $10,260,000 | thousands by filing date | |
| MERGE HEALTHCARE INC | 589499102 | COM | 4,628,500 | $10,183,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 1,200,000 | $8,568,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HOLDINGS | 71426V108 | COM | 1,073,000 | $8,241,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 1,500,000 | $8,130,000 | thousands by filing date | |
| REDHILL BIOPHARMA LTD | 757468103 | ADR | 605,800 | $7,978,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 838,700 | $7,808,000 | thousands by filing date | |
| MYLAN INC | 628530107 | COM | 169,100 | $7,692,000 | thousands by filing date | |
| SYNAGEVA BIOPHARMA CORP | 87159A103 | COM | 111,100 | $7,641,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 180,000 | $7,486,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 112,000 | $7,263,000 | thousands by filing date | |
| INSPIREMD INC | 45779A309 | COM | 3,150,000 | $6,930,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 80,000 | $6,480,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 5,702,000 | $6,386,000 | thousands by filing date | |
| IMPAX LABORATORIES INC | 45256B101 | COM | 250,000 | $5,928,000 | thousands by filing date | call |
| MIMEDX GROUP INC | 602496101 | COM | 795,400 | $5,671,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 158,000 | $5,042,000 | thousands by filing date | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 580,000 | $5,040,000 | thousands by filing date | |
| DAVITA INC COM | 23918K108 | Stock | 65,000 | $4,754,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 170,000 | $4,017,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 692,900 | $3,534,000 | thousands by filing date | |
| UROPLASTY INC | 917277204 | COM NEW | 1,363,500 | $3,409,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 271,700 | $3,209,000 | thousands by filing date | |
| CURIS INC | 231269101 | COM | 1,950,100 | $2,750,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 350,000 | $2,499,000 | thousands by filing date | call |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 300,000 | $2,499,000 | thousands by filing date | |
| NEWLINK GENETICS CORP | 651511107 | COM | 100,000 | $2,142,000 | thousands by filing date | call |
| BACTERIN INTL HLDGS INC | 05644R200 | COM NEW | 475,439 | $2,130,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 1,135,000 | $1,748,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 158,000 | $1,577,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266SAA4 | NOTE 2.250%12/1 | 1,000,000 | $898,000 | thousands by filing date | principal |
| BIOMARIN PHARMACEUTICAL INC | 09061GAF8 | NOTE 1.500%10/1 | 500,000 | $550,000 | thousands by filing date | principal |
| BIOMARIN PHARMACEUTICAL INC | 09061GAE1 | NOTE 0.750%10/1 | 500,000 | $529,000 | thousands by filing date | principal |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 400,000 | $436,000 | thousands by filing date | |
| BIODEL INC | 09064M204 | COM | 209,700 | $350,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-14-001849 | this filing | 2014-11-14 | acceptance time not in the bulk data set |